Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology test… Read more
Market Cap & Net Worth: Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)
Shin Nippon Biomedical Laboratories, Ltd. (PINK:SBLOF) has a market capitalization of $395.92 Million ($395.92 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #22383 globally and #7932 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shin Nippon Biomedical Laboratories, Ltd.'s stock price $9.51 by its total outstanding shares 41631836 (41.63 Million).
Shin Nippon Biomedical Laboratories, Ltd. Market Cap History: 2023 to 2025
Shin Nippon Biomedical Laboratories, Ltd.'s market capitalization history from 2023 to 2025. Data shows change from $701.13 Million to $395.92 Million (-25.78% CAGR).
Shin Nippon Biomedical Laboratories, Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shin Nippon Biomedical Laboratories, Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Shin Nippon Biomedical Laboratories, Ltd.'s market cap is 0.01 times its annual revenue
0.68x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.08x
Shin Nippon Biomedical Laboratories, Ltd.'s market cap is 0.08 times its annual earnings
359.02x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $701.13 Million | $25.09 Billion | $6.06 Billion | 0.03x | 0.12x |
| 2024 | $706.49 Million | $26.45 Billion | $5.53 Billion | 0.03x | 0.13x |
| 2025 | $395.92 Million | $32.41 Billion | $4.92 Billion | 0.01x | 0.08x |
Competitor Companies of SBLOF by Market Capitalization
Companies near Shin Nippon Biomedical Laboratories, Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Shin Nippon Biomedical Laboratories, Ltd. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Shin Nippon Biomedical Laboratories, Ltd. Historical Marketcap From 2023 to 2025
Between 2023 and today, Shin Nippon Biomedical Laboratories, Ltd.'s market cap moved from $701.13 Million to $ 395.92 Million, with a yearly change of -25.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $395.92 Million | -43.96% |
| 2024 | $706.49 Million | +0.76% |
| 2023 | $701.13 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Shin Nippon Biomedical Laboratories, Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $395.92 Million USD |
| MoneyControl | $395.92 Million USD |
| MarketWatch | $395.92 Million USD |
| marketcap.company | $395.92 Million USD |
| Reuters | $395.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.